Evidence map›Paper›PMID 28130274›Full record

ArticleJournal of lipid research2017

Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis.

Kazuyuki Kasahara, Takeshi Tanoue, Tomoya Yamashita, Keiko Yodoi, Takuya Matsumoto, Takuo Emoto, Taiji Mizoguchi, Tomohiro Hayashi, Naoki Kitano, Naoto Sasaki and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. mSystems · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Intestinal and fecal pH in human health.Frontiers in microbiomes · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Microbiome and Cardiovascular Disease.Handbook of experimental pharmacology · 2022
    Article
  18. Diet-gut microbiota interactions on cardiovascular disease.Computational and structural biotechnology journal · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kazuyuki KasaharaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Takeshi TanoueRIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Tomoya YamashitaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan tomoya@med.kobe-u.ac.jp.
Keiko YodoiDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Takuya MatsumotoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Takuo EmotoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Taiji MizoguchiDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Tomohiro HayashiDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Naoki KitanoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Naoto SasakiDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Koji AtarashiRIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Kenya HondaRIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Ken-Ichi HirataDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Kobe University · JPRIKEN Center for Integrative Medical Sciences · JPUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota were shown to play critical roles in the development of atherosclerosis, but the detailed mechanism is limited. The purpose of this study is to clarify the influence of gut microbiota on atherogenesis via lipid metabolism and systemic inflammation. Germ-free or conventionally raised (Conv) ApoE-deficient (

Indexed as

AnimalsApolipoproteins EAtherosclerosisBacteriaCholesterolCholesterol 7-alpha-HydroxylaseDietDisease Models, AnimalFibroblast Growth FactorsGastrointestinal MicrobiomeHomeostasisHumansIleumInflammationLipid MetabolismMiceApolipoproteins ECholesterolCholesterol 7-alpha-Hydroxylasefibroblast growth factor 15, mouseFibroblast Growth FactorsReceptor, Fibroblast Growth Factor, Type 4bile acid metabolismcholesterol/metabolismgut microbiotamacrophagesnuclear receptors/farnesoid X receptor

Identifiers

PMID28130274
PMCPMC5335582
OpenAlexW2582177106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.